• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD. THORAFLEX HYBRID; THORAFLEX HYBRID PLEXUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD. THORAFLEX HYBRID; THORAFLEX HYBRID PLEXUS Back to Search Results
Catalog Number THP2426X100B-G
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 02/08/2020
Event Type  Injury  
Event Description
Unanticipated adverse event of carotid arteria dissection with thrombosis was reported from thor study for the patient implanted with thoraflex hybrid device.Adverse event occurred on the (b)(6) 2020.Adverse event was reported as possibly related to device, procedure, and patient's pre-existing condition.Re-operation was carried out to remove thrombus.Adverse event resolved with sequelae on (b)(6) 2020.Initially 3 events were reported (stroke, thrombus, haematoma) in fda report 9612515-2022-00016 as all three events occurred to the same patient implanted with thoraflex hybrid.However further consideration was given, and three events were split into three difeerent fda reports.Follow up report for stroke event was submitted under reference number 9612515-2022-00016.Additional report for haematoma (fda reference 9612515-2022-00023) will be submitted.
 
Manufacturer Narrative
(b)(4).Carotid artery dissection with thrombosis occurred on the (b)(6) 2020.Adverse event was reported as unanticipated and possibly related to device, procedure, and patient's pre-existing condition.Re-operation was carried out to remove thrombus.Adverse event resolved with sequelae on (b)(6) 2020.(b)(4).Thrombus formation event reported as possibly device related; however, device deficiency that possibly caused the event was not determined.(b)(4).Type of investigation: a 5 year review ( jan 17 - sep 22) of similar complaints (occlusion/thrombosis in thoraflex hybrid branded product) gave an occurrence rate of (b)(4) (complaints v sales) ( no negative trend was identified.Scans have been requested from the site.Device remains in situ.The review of quality, manufacturing and physical test records showed that the device was manufactured to the intended specifications.Investigation findings: no issue has been found upon review of the retained device history records for this device investigation conclusions: additional information and ct scans has been requested from the study site.
 
Manufacturer Narrative
Manufacturer narrative : section h6.Investigation findings : 213 - no device problem found - no issue has been found upon review of the retained device history records for this device.Further information from the site received on 15 nov 22 the site has spoken to the clinician who had confirmed that the event of thrombus is not considered to be device related.Scans were received and reviewed on 15 dec 22.The post -implant ct imaging has been performed after the re intervention to resolve the stroke.It is therefore not possible to give the conclusive review of the scans.Investigation conclusion: 67 - no problem detected - study site confirmed the event was not device related.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.
 
Event Description
Tis report is being submitted as follow up #1 for mfg report # to provide closure information for comp (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THORAFLEX HYBRID
Type of Device
THORAFLEX HYBRID PLEXUS
Manufacturer (Section D)
VASCUTEK LTD.
newmains avenue
inchinnan business park
glasgow, renfrewshire PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD.
newmains avenue
inchinnan business park
glasgow, renfrewshire PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
glasgow, renfrewshire PA4 9-RR
UK   PA4 9RR
MDR Report Key15779720
MDR Text Key303750392
Report Number9612515-2022-00021
Device Sequence Number1
Product Code QSK
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2021
Device Catalogue NumberTHP2426X100B-G
Device Lot Number17841051
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/05/2022
Date Device Manufactured04/25/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-